Related Experiment Video
Updated: May 25, 2025

Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
Exploring the microbiota-gut-brain axis: impact on brain structure and function
Lidya K Yassin1, Mohammed M Nakhal1, Alreem Alderei1
1Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Abstract:
The microbiota-gut-brain axis (MGBA) plays a significant role in the maintenance of brain structure and function. The MGBA serves as a conduit between the CNS and the ENS, facilitating communication between the emotional and cognitive centers of the brain via diverse pathways. In the initial stages of this review, we will examine the way how MGBA affects neurogenesis, neuronal dendritic morphology, axonal myelination, microglia structure, brain blood barrier (BBB) structure and permeability, and synaptic structure. Furthermore, we will review the potential mechanistic pathways of neuroplasticity through MGBA influence. The short-chain fatty acids (SCFAs) play a pivotal role in the MGBA, where they can modify the BBB. We will therefore discuss how SCFAs can influence microglia, neuronal, and astrocyte function, as well as their role in brain disorders such as Alzheimer's disease (AD), and Parkinson's disease (PD). Subsequently, we will examine the technical strategies employed to study MGBA interactions, including using germ-free (GF) animals, probiotics, fecal microbiota transplantation (FMT), and antibiotics-induced dysbiosis. Finally, we will examine how particular bacterial strains can affect brain structure and function. By gaining a deeper understanding of the MGBA, it may be possible to facilitate research into microbial-based pharmacological interventions and therapeutic strategies for neurological diseases.
Insights
The microbiota-gut-brain axis (MGBA) impacts brain health by influencing neurogenesis and neural structures. Understanding MGBA mechanisms, including short-chain fatty acids (SCFAs), offers potential for treating neurological disorders like Alzheimer's and Parkinson's disease.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- The microbiota-gut-brain axis (MGBA) is crucial for brain structure and function, mediating communication between the central nervous system (CNS) and enteric nervous system (ENS).
- Dysregulation of the MGBA is implicated in various neurological conditions, highlighting the need to understand its intricate mechanisms.
Purpose of the Study:
- To review how the MGBA influences key aspects of brain structure and function, including neurogenesis, neuronal morphology, myelination, microglia, the blood-brain barrier (BBB), and synaptic plasticity.
- To explore the mechanistic pathways by which the MGBA affects neuroplasticity, with a focus on the role of short-chain fatty acids (SCFAs).
- To examine the utility of various technical strategies for studying MGBA interactions and their implications for neurological diseases.
Main Methods:
- Literature review focusing on the impact of the MGBA on neurogenesis, neuronal structure, BBB integrity, and synaptic function.
- Analysis of the role of short-chain fatty acids (SCFAs) in modulating the BBB, glial cells, and neuronal function.
- Examination of methodologies such as germ-free (GF) animal models, probiotics, fecal microbiota transplantation (FMT), and antibiotic-induced dysbiosis.
Main Results:
- The MGBA significantly influences neurogenesis, dendritic morphology, axonal myelination, microglia, BBB structure and permeability, and synaptic structure.
- Short-chain fatty acids (SCFAs) play a critical role in modifying the BBB and influencing glial and neuronal function, impacting conditions like Alzheimer's and Parkinson's disease.
- Specific bacterial strains demonstrate the capacity to alter brain structure and function, underscoring the targeted therapeutic potential.
Conclusions:
- The MGBA is a critical regulator of brain health, influencing neural plasticity and function through diverse pathways.
- Understanding the MGBA's role, particularly the influence of SCFAs and specific microbial communities, is vital for developing novel therapeutic strategies for neurological disorders.
- Microbial-based interventions hold promise for treating complex brain diseases such as Alzheimer's and Parkinson's disease.
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Neural Regulation
Physiology of Enteric Nervous System and Gut Health
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
What is Monogastric Digestion?

